Carregant...
Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents
BACKGROUND: The risk for cardiovascular events associated with systemic therapies for psoriasis, including biologics, is unclear. METHODS: We used administrative data from Medicare 2006 through 2011 to identify psoriasis patients who initiated systemic treatments. We estimated incidence rates of hos...
Guardat en:
| Publicat a: | J Psoriasis Psoriatic Arthritis |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5800414/ https://ncbi.nlm.nih.gov/pubmed/29423460 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|